Arthritis Drugs associated with Deadly Infections & Cancer

Lawyers and Attorneys working at our firm are investigating the association between Humira, Cimzia, Enbrel, and Remicade with deadly infections and cancer.

U.S. Food and Drug Administration announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing warnings, in the Warnings and Precaution sections of the drugs’ prescribing information and Medication Guides, on the risk of developing deadly opportunistic fungal infections.

The four drugs, known as tumor necrosis factor alpha blockers (TNF-alpha blockers), which suppress the immune system, are approved to treat a variety of conditions which may include rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, and Crohn’s disease.

FDA today exercised its new authority under the Food and Drug Administration Amendments Act of 2007 to require manufacturers of TNF inhibitors to make safety-related changes to prescribing information, or labeling.

Since the initial approval of the four TNF blockers, the prescribing information for these drugs has included information about the risk of serious infections, including fungal infections. However, based on reports reviewed by FDA, health care professionals are not consistently recognizing cases of histoplasmosis and other invasive fungal infections, leading to delays in treatment.

Patients taking TNF blockers should be aware that they are more susceptible to serious fungal infections. Those who develop a persistent fever, cough, shortness of breath, and fatigue should promptly seek medical attention. To assist in the diagnosis, those being treated with TNF blockers should tell their health care professionals where they live and what areas they have recently visited. Patients who develop a fungal infection may be advised to stop the TNF blocker until they recover.

FDA has reviewed 240 reports of histoplasmosis, an infection caused by the fungusHistoplasma capsulatum, in patients being treated with Enbrel, Humira, or Remicade. The majority of the reports involved people in the Ohio River and Mississippi River valleys (the fungus is commonly found in those areas). In at least 21 of the reports, histoplasmosis was initially not recognized by health care professionals, and antifungal treatment was delayed. Twelve of those patients died.

The FDA reviewed one reported case of histoplasmosis in a patient taking Cimzia. The FDA also has received reports of cases of coccidioidomycosis and blastomycosis, including deaths, in patients treated with TNF blockers.

TNF blocker manufacturers are required to submit safety labeling changes, including strengthened warnings and revisions to the Medication Guides to the FDA within 30 days or to provide a reason why they do not believe labeling changes are necessary.

SIGNS AND SYMPTOMS OF FUNGAL INFECTIONS

  • Alopecia – loss of hair; 
  • Annular lesions – ring shaped lesions on the skin; 
  • Pustules - small, inflamed, pus-filled, blister-like lesions on the skin surface. 
  • Rash; and 
  • Onycholysis – the painless separation of the nail from the nail bed 

CONTACT A HUMIRA, CIMZIA, REMICADE, AND ENBREL ATTORNEY NOW!

If you or a loved one suffered from a serious adverse reaction from the use of Humira, Cimzia, Remicade, or Enbrel, you have valuable legal rights. Please fill out our online form and a Humira, Cimzia, Remicade, or Enbrel attorney will contact you within 24 hours.



No comments yet.

Leave a Reply

GET HELP NOW!

Your Name (required)

Your Email (required)

Your Phone Number (required)

Tell Us How We Can Help

Latest Drug Injury News

Pfizer Birth Control Recall Could Result In Accidental Pregnancies

The reason a woman takes a birth control pill, is to prevent unwanted, or accidental pregnancies.  And, although the pills are not 100% effective, most women assume they will be protected from the life changing event.  But, a manufacturing mix-up is leaving women at an even greater risk of unwanted pregnancies. Apparently the mix up [...]

Heartburn Medication Users Raise Hip Fracture Risk By As Much As 50%

Women who take certain drugs for heartburn, acid reflux and peptic ulcers are raising their risk of hip fractures by as much as 50 percent, according to researchers at Harvard Medical School and Massachusetts General Hospital in Boston. The drugs, called proton pump inhibitors (PPI’s) are used by millions around the world who suffer from [...]

Antiepileptic Drugs May Carry Greater Birth Defect Risks Than Previously Thought

Doctors used to tell women with epilepsy not to have children, because the only available medications to treat the disorder also increased the risk of birth defects.  But according to a May 2011 study in the Journal of the American Medical Association, newer antiepileptic medications used during the first trimester carry no such risks. However, [...]

Drugs Used To Fight Transmission Of HIV To Unborn Baby May Ultimately Cause Birth Defects

Expectant mothers with HIV have some hope of preventing the transmission of the deadly virus to their unborn baby, with a special kind of drug called antiretrovirals.  But, unfortunately based on new research, these drugs may come with several possible birth defects. Everyday Health explained that Vassiliki Cartsos, associate professor and director of graduate orthodontics [...]

Antipsychotic Drug Risperdal, Although Very Effective, Comes With Serious Side Effects

A new study has found that while Risperdal, an antipsychotic drug, works well when it comes to treating childhood bi-polar disorder, the drug’s metabolic side effects need to be taken seriously. Risperdal is a newer atypical antipsychotic drug. It is manufactured by Jannsen Pharmaceuticals, a division of Johnson & Johnson. Risperdal has been known to [...]

Latest Medical Device Injury News

Lap-Band Surgery Centers In Hot Water With Death Toll Rising & Possible Fraudulent Activity

Just last week we reported that a group of Democratic lawmakers were calling on the Republicans who control the House Energy and Commerce Committee for a safety review concerning 2 controversial medical devices.  Now it just so happens that one of those devices, The Lap-Band, is again in the news, and the topic of this [...]

Johnson & Johnson Suffering From Manufacturing Issues and Recalls

The drug & medical device giant Johnson & Johnson seems to be a name that is coming up a lot lately; from the controversial chemicals found in baby products to the major artificial hip recall surrounding DuPuy Orthopaedic’s, they continually seem to be on the radar. Now, in their just released last quarter financial statement [...]

Late Breaking News Concerning Breast Implant Scandal- CEO Arrested & US Women Are Warned Of Dangers

Recently we reported about the now defunct French company Poly Implant Prothese (PIP) that manufactured defective silicone implants.  We told you about other countries around the world and how they each are responding to the anxieties over the defective products. Now, as of today, January 26, 2012, the former head of a French company at [...]

Lawmakers Seeking Safety Review In Regards to Transvaginal Mesh & Lap-Band Medical Devices

  For the second time, four Democratic lawmakers are seeking hearings into two controversial medical devices, the Lap-Band surgical weight loss device, made by Allergan Inc. and transvaginal meshes made by Johnson & Johnson. In a letter sent last week, the group, led by U.S. Representative Henry Waxman of California, asserts that both transvaginal mesh [...]

FDA Warns DuPuy Company To Stop And Comply Or Face Consequences

Johnson & Johnson in the hot seat again, as the U.S. Food and Drug Administration (FDA) just issued a warning to Johnson & Johnson’s DePuy Orthopaedics for marketing a number of unapproved medical device components. The drug and device giant’s subsidiary sold more than a dozen different orthopedic devices without ever having received required regulatory [...]